Dr. Pedroza is a specialist in molecular biology and cancer research, with a focus on identifying molecular markers associated with treatment resistance in ovarian cancer. His research also explores the role of cellular exosomes in modulating the tumor microenvironment and influencing the response to cisplatin therapy. Dr. Alvarez-Gomez is aspecialist in genetics and cancer risk assessment. Currently, she is the chief of the Hereditary Cancer Clinic at National Cancer Institute (INCAN), Mexico. Dr. Alvarez's multidisciplinary clinical and research program emphasizes the relevance of the translational medicine in diagnosis, treatment and assessment of patients with inherited cancer and their families.